Rosh Women's Health Practice Exam

The recommended treatment for a patient with eclampsia experiencing a seizure at 35 weeks of gestation is to administer magnesium sulfate immediately and proceed for prompt cesarean delivery. This approach is critical for several reasons.

First, magnesium sulfate is the first-line treatment for preventing further seizures in women with eclampsia. Administering it immediately after a seizure not only helps to stabilize the mother but also mitigates the risk of complications for both the mother and the fetus, as ongoing seizures can lead to severe maternal and neonatal morbidity.

Secondly, when a patient with eclampsia presents in active seizure, especially at a gestational age of 35 weeks, delivery of the fetus is generally indicated due to the increased risks associated with continued pregnancy and the condition of eclampsia. A prompt cesarean delivery allows for the immediate removal of the fetus, which can alleviate the mother's condition and protect her health.

While other options may suggest administering magnesium sulfate, they do not prioritize the safety of both the mother and the fetus as effectively as the chosen course of action. Inducing labor, especially under unstable conditions like ongoing seizures, may not be advisable if the well-being of the mother is compromised. Additionally, delaying cesarean delivery can